SKYSTAR BIO-PHARMACEUTICAL CO Operating Expenses
SKYSTAR BIO-PHARMACEUTICAL CO reported Operating Expenses of $3.36 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for the quarter ending 2014-09-30 was $3.36M, a 3.25% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for the quarter ending 2014-06-30 was $2.99M, a 111.96% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for the quarter ending 2014-03-31 was $1.65M, a 7.93% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for the quarter ending 2013-12-31 was $2.06M, a 43.83% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for fiscal 2013 was $8.48M, a 14.72% decline from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for fiscal 2012 was $9.94M, a 9.43% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for fiscal 2011 was $10.98M, a 47.62% increase from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO operating expenses for fiscal 2010 was $7.43M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2014-09-30 | $3.36M 10-Q · filed 2014-11-14 | $6.35M derived: sum of 2 quarters · filed 2014-11-14 | $8.00M 10-Q · filed 2014-11-14 | $10.07M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $2.99M 10-Q · filed 2014-08-14 | $4.64M 10-Q · filed 2014-08-14 | $6.70M derived: sum of 3 quarters · filed 2014-08-14 | $10.18M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $1.65M 10-Q · filed 2014-05-15 | $3.71M derived: sum of 2 quarters · filed 2014-05-15 | $7.19M derived: sum of 3 quarters · filed 2014-11-14 | $8.60M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $5.54M derived: sum of 2 quarters · filed 2014-11-14 | $6.95M derived: sum of 3 quarters · filed 2014-11-14 | $8.48M 10-K · filed 2014-03-31 |
| 2013-09-30 | $3.48M 10-Q · filed 2014-11-14 | $4.89M derived: sum of 2 quarters · filed 2014-11-14 | $6.42M 10-Q · filed 2014-11-14 | $10.09M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $1.41M 10-Q · filed 2014-08-14 | $2.94M 10-Q · filed 2014-08-14 | $6.61M derived: sum of 3 quarters · filed 2014-08-14 | $8.23M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $1.53M 10-Q · filed 2014-05-15 | $5.20M derived: sum of 2 quarters · filed 2014-05-15 | $6.82M derived: sum of 3 quarters · filed 2014-05-15 | $9.66M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $5.29M derived: sum of 2 quarters · filed 2014-03-31 | $8.13M derived: sum of 3 quarters · filed 2014-03-31 | $9.94M 10-K · filed 2014-03-31 |
| 2012-09-30 | $1.62M 10-Q · filed 2013-11-14 | $4.46M derived: sum of 2 quarters · filed 2013-11-14 | $6.27M 10-Q · filed 2013-11-14 | $10.50M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $2.84M 10-Q · filed 2013-08-14 | $4.65M 10-Q · filed 2013-08-14 | $8.88M derived: sum of 3 quarters · filed 2013-08-14 | $10.75M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $1.81M 10-Q · filed 2013-05-15 | $6.04M derived: sum of 2 quarters · filed 2013-05-15 | $7.91M derived: sum of 3 quarters · filed 2013-05-15 | $10.84M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $4.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $6.10M derived: sum of 2 quarters · filed 2013-04-01 | $9.02M derived: sum of 3 quarters · filed 2013-04-01 | $10.98M 10-K · filed 2013-04-01 |
| 2011-09-30 | $1.87M 10-Q · filed 2012-11-14 | $4.79M derived: sum of 2 quarters · filed 2012-11-14 | $6.75M 10-Q · filed 2012-11-14 | $9.53M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $2.93M 10-Q/A · filed 2012-09-13 | $4.88M 10-Q/A · filed 2012-09-13 | $7.66M derived: sum of 3 quarters · filed 2012-09-13 | $9.86M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $1.95M 10-Q · filed 2012-05-15 | $4.73M derived: sum of 2 quarters · filed 2012-05-15 | $6.93M derived: sum of 3 quarters · filed 2012-05-15 | $8.55M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $4.98M derived: sum of 2 quarters · filed 2012-03-30 | $6.60M derived: sum of 3 quarters · filed 2012-03-30 | $7.43M 10-K · filed 2012-03-30 |
| 2010-09-30 | $2.20M 10-Q · filed 2011-11-14 | $3.82M derived: sum of 2 quarters · filed 2011-11-14 | $4.66M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $1.62M 10-Q/A · filed 2011-09-21 | $2.46M 10-Q/A · filed 2011-09-21 |